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Background
Persistent systemic immune activation plays a central role
in the pathogenesis of HIV disease. Impairment of the
intestinal barrier and subsequent microbial translocation
might be involved in chronic immune activation. Th17
cells are important in the maintenance of intact epithelium
and host defense against extracellular pathogens. The ratio
between the two closely related CD4 subsets Th17 and
Tregs has been recently found to shrink with HIV/SIV dis-
ease progression. The aim of the study was to analyze, in
patients with early primary HIV infection (PHI), the rela-
tionship between Th17/Treg ratio and the immune activa-
tion set point, known to predict disease progression.
Methods
27 patients with early PHI were included in a prospective
longitudinal study and followed-up for 6 months. T-cell
activation and CD4+CD25+CD127lowFoxp3+ Treg fre-
quency were assessed on fresh PBMC. Th17 cells were
quantified by intracellular cytokine staining on sorted per-
ipheral CD4 T cells stimulated with PMA/ionomycin for
5h. Correlations were assessed using spearman non-para-
metric tests. Plasma I-FABP, a marker of mucosal damages
and soluble CD14 (sCD14) were measured by ELISA.
Results
A strong negative relationship was found at baseline
between the Th17/Treg ratio and the proportion of acti-
vated CD8 T cells expressing CD38/HLA-DR (p=0.008) or
Ki-67 (P=0.001). At baseline, Th17/Treg ratios also nega-
tively correlated with sCD14 plasma levels (p=0.003).
I-FABP levels, which were similar to controls at baseline,
increased at month 6. The Th17/Treg ratio at baseline (but
not the proportion of Th17 cells) negatively correlated
with the frequency of HLA-DR+CD38+ or Ki-67+ CD8
T cells at month 6, defining the immune activation set
point (p=0.02 and p=0.0005 respectively). sCD14 plasma
levels were also found to predict the immune set point
(p=0.02).
Conclusion
Our data do not support early mucosal damages in PHI.
However, the early Th17/Treg balance correlates with
sCD14 levels and predicts the immune activation set
point.
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